Table 1.
Physiological and pathophysiological function | Cell type or tissues involved | Refs. |
---|---|---|
Interaction with EGFR and ERBB4 for cell signaling | Multiple cell types that express EGFR and ERBB4 | 1 |
Induction of proliferation of HSPCs | Bone marrow hematopoietic and stromal cells | 13,14 |
Development of the heart structure and function | Endothelial cells | 17 |
Liver function | Hepatocytes | 22–24 |
Renal function | Renal endothelial cells | 19 |
Renal podocytes | 21 | |
Renal tubular epithelial cells | 112,116 | |
EGFR transactivation | Multiple cell types under stress environments | 12,29 |
Induction of insulin resistance | Adipocytes and skeletal muscle cells | 37 |
Interaction with adiponectin | Vascular smooth muscle cells | 82,83 |
Induction of neointimal thickness | Vascular smooth muscle cells | 49 |
Regulation of hepatic VLDL production | LSECs or hepatocytes | 92 |
Regulation of inflammatory cytokine expression | Vascular endothelial cells | 34 |
Atherosclerosis and aneurysm development | Aortic smooth muscle cells | 61,98,99,102,103 |
Interaction with diphtheria toxin | Multiple cell types | 134 |
EGFR, epidermal growth factor receptor; HSPCs, hematopoietic stem and progenitor cells; LSECs, liver sinusoidal endothelial cells; VLDL, very-low-density lipoprotein.